ANGI vs META

ANGI's Piotroski F-Score of 4/9 indicates weak financial health, falling short of the 7-9 threshold for strong stability. The absence of an Altman Z-Score raises concern over potential distress risk, especially given the company's declining revenue and earnings trends. While the Graham Number ($22.13) suggests undervaluation, the intrinsic value estimate ($6.58) and current price ($7.39) imply a modest premium, unsupported by consistent profitability or growth. The stock has underperformed dramatically over the past 5 years, with a 95.6% decline, and recent earnings misses have been severe, averaging a -32.28% surprise over the last four quarters. These factors collectively point to a fundamentally weak and deteriorating business.

META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across profitability, leverage, and operating efficiency. While the current price of $612.42 trades at a premium to the Graham Number ($213.17) and the growth-based Intrinsic Value ($542.14), the PEG ratio of 0.94 suggests the stock is undervalued relative to its high growth rate. Strong revenue growth (23.8%) and a low forward P/E (17.03) outweigh the bearish technical trend and insider selling. The company's dominant market position and consistent earnings beats support a bullish long-term outlook.